BioSpace News Archive

Planmeca announces new high-performance chairside 3D printer

Planmeca is introducing a new chairside 3D printer to its product offering.

March 12, 2019
·
2 min read
Planmeca Viso™ product line of next-gen CBCT imaging units expands

Planmeca has introduced a new member to its growing Planmeca Viso™ product family of next generation imaging units.

March 12, 2019
·
2 min read
Planmeca Romexis® Dental PACS combines treatment planning and archiving of all images – also 3rd party data – in one database

Planmeca is pleased to introduce Planmeca Romexis® Dental PACS, the first software platform to allow image archiving, viewing and treatment planning in a single software.

March 12, 2019
·
2 min read
FDA

Sonavex Receives FDA 510(k) Clearance for EchoSure

Medical device company receives second FDA clearance, adding blood flow monitoring technology to portfolio

March 12, 2019
·
2 min read
Business

Tiburio Therapeutics Inc. Appoints Nerissa Kreher, MD, Chief Medical Officer

Tiburio Therapeutics Inc. (Tiburio), a private biopharmaceutical company focused on developing treatments for rare neuroendocrine tumors and endocrine diseases, today announced the appointment of Nerissa Kreher, MD, to the newly created position of Chief Medical Officer.

March 12, 2019
·
3 min read
Biotech Beach

Forge Therapeutics To Present At The 18th Annual Needham & Company Healthcare Conference

Presentation will focus on Forge’s novel chemistry platform, BLACKSMITH, and its therapeutic applications

March 12, 2019
·
1 min read
Deals

Neovasc Announces Proposed Public Offering of Common Shares - March 12, 2019

Neovasc Inc. announced that it has commenced a proposed underwritten public offering of common shares of the Company.

March 12, 2019
·
9 min read
Deals

Ligand to Participate in Four Upcoming Investor Conferences

Ligand Pharmaceuticals Incorporated announces that company executives are scheduled to participate in the following upcoming investor conferences

March 12, 2019
·
2 min read
Business

Corindus Reports Fourth Quarter and Full Year 2018 Results

Submitted Neurovascular Indication Marking Important Step toward Addressing Stroke Market; Raised $19.8 Million to Fund Ongoing Innovation

March 12, 2019
·
11 min read
Deals

Inovio Pharmaceuticals Reports 2018 Fourth Quarter and Year-End Financial Results

Inovio Pharmaceuticals, Inc., a late-stage biotechnology company focused on the development and commercialization of DNA immunotherapies targeted against cancers and infectious diseases, reported financial results for the fourth quarter and year ended December 31, 2018.

March 12, 2019
·
17 min read